James Harnett

1.5k total citations
59 papers, 1.1k citations indexed

About

James Harnett is a scholar working on Epidemiology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James Harnett has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Psychiatry and Mental health and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James Harnett's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Musculoskeletal pain and rehabilitation (6 papers) and Opioid Use Disorder Treatment (6 papers). James Harnett is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Musculoskeletal pain and rehabilitation (6 papers) and Opioid Use Disorder Treatment (6 papers). James Harnett collaborates with scholars based in United States, United Kingdom and Spain. James Harnett's co-authors include Brian J. Cuffel, Jack Mardekian, Onur Başer, Stuart L. Silverman, David Gruben, Siddhesh Kamat, John W. Newcomer, Elaine H. Morrato, Robert A. Gerber and Andrew Koenig and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Diabetes Care.

In The Last Decade

James Harnett

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Harnett United States	18	417	203	159	142	126	59	1.1k
Marion Bertrand France	21	200 0.5×	162 0.8×	95 0.6×	40 0.3×	126 1.0×	51	1.4k
Michał Matyjaszczyk Poland	5	469 1.1×	166 0.8×	124 0.8×	41 0.3×	326 2.6×	6	2.1k
Sarah Clifford United Kingdom	13	250 0.6×	92 0.5×	99 0.6×	29 0.2×	212 1.7×	22	1.4k
R. Jean Shapiro Canada	19	279 0.7×	193 1.0×	376 2.4×	93 0.7×	42 0.3×	45	1.3k
Andrew Maguire United Kingdom	19	71 0.2×	278 1.4×	128 0.8×	176 1.2×	77 0.6×	42	1.3k
Betina T. Blak United Kingdom	12	103 0.2×	215 1.1×	297 1.9×	41 0.3×	77 0.6×	24	1.1k
Josep Darbà Spain	16	160 0.4×	131 0.6×	61 0.4×	57 0.4×	191 1.5×	109	906
Patrícia Caetano Canada	21	130 0.3×	271 1.3×	43 0.3×	41 0.3×	199 1.6×	32	2.0k
Jonathan Belsey United Kingdom	21	118 0.3×	129 0.6×	144 0.9×	37 0.3×	89 0.7×	64	1.8k
Matthew Reaney United Kingdom	23	130 0.3×	303 1.5×	836 5.3×	75 0.5×	203 1.6×	106	2.0k

Countries citing papers authored by James Harnett

Since Specialization

Citations

This map shows the geographic impact of James Harnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Harnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Harnett more than expected).

Fields of papers citing papers by James Harnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Harnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Harnett. The network helps show where James Harnett may publish in the future.

Co-authorship network of co-authors of James Harnett

This figure shows the co-authorship network connecting the top 25 collaborators of James Harnett. A scholar is included among the top collaborators of James Harnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Harnett. James Harnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoffman, James E., Naresh Bumma, Joshua Richter, et al.. (2025). Patient-Reported Quality of Life with Linvoseltamab in Triple-Class Exposed Patients with Relapsed/Refractory Multiple Myeloma: 2-year Results from the LINKER-MM1 Phase 1/2 Clinical Trial. Clinical Lymphoma Myeloma & Leukemia. 25. S116–S116. 1 indexed citations

Zonder, Jeffrey A., Hans C. Lee, Joshua Richter, et al.. (2024). P-403 Indirect Comparison of Linvoseltamab Versus Selinexor Plus Dexamethasone for Penta-Exposed Relapsed/Refractory Multiple Myeloma (RRMM). Clinical Lymphoma Myeloma & Leukemia. 24. S267–S267. 1 indexed citations

Solà-Morales, Oriol, Lesley H. Curtis, Deborah Casso, et al.. (2023). Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions. Clinical Pharmacology & Therapeutics. 114(2). 325–355. 16 indexed citations

Ge, Wenzhen, Ning Wu, Jessica J. Jalbert, et al.. (2022). Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy. Cancer Management and Research. Volume 14. 3191–3202. 4 indexed citations

Ge, Wenzhen, Ning Wu, Ruben G.W. Quek, et al.. (2022). Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer. Advances in Therapy. 39(10). 4645–4662.

Kearney, Mairead, Charles Knott, F Lamy, et al.. (2020). PCN341 Treatment Patterns and Clinical Outcomes in Patients with Locally Advanced or Metastatic Urothelial Cancer in England: Results of a Longitudinal Observational Cohort Study. Value in Health. 23. S483–S483. 3 indexed citations

Harnett, James, et al.. (2018). Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey. Digestive Diseases and Sciences. 63(11). 2864–2873. 27 indexed citations

Pasquale, Margaret K., et al.. (2016). ULCERATIVE COLITIS TREATMENT PATTERNS AND COST OF CARE. Value in Health. 19(3). A314–A314. 1 indexed citations

Roland, Carl L., et al.. (2012). PSY9 Prevalence of Opioid Abuse and Associated Health Care Resource Utilization and Costs in a Managed Care Population. Value in Health. 15(4). A99–A100. 1 indexed citations

10.

Udall, Margarita, James Harnett, & Jack Mardekian. (2011). Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy. Journal of Medical Economics. 15(2). 361–370. 13 indexed citations

11.

Zeng, Feng, Chieh-I Chen, Vera Mastey, et al.. (2011). Effects of Copayment on Initiation of Smoking Cessation Pharmacotherapy: An Analysis of Varenicline Reversed Claims. Clinical Therapeutics. 33(2). 225–234. 16 indexed citations

12.

Citrome, Leslie, Christopher Reist, Liisa Palmer, et al.. (2009). Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder. Schizophrenia Research. 115(2-3). 115–120. 16 indexed citations

13.

Kleinman, Nathan L., et al.. (2009). Burden of Fibromyalgia and Comparisons With Osteoarthritis in the Workforce. Journal of Occupational and Environmental Medicine. 51(12). 1384–1393. 51 indexed citations

14.

Druss, Benjamin G., et al.. (2008). Medical Services for Clients in Community Mental Health Centers: Results From a National Survey. Psychiatric Services. 59(8). 917–920. 61 indexed citations

15.

Citrome, Leslie, Christopher Reist, Liisa Palmer, et al.. (2008). Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder. Schizophrenia Research. 108(1-3). 238–244. 28 indexed citations

16.

Scranton, Richard E., Elizabeth Lawler, Marc Botteman, et al.. (2007). Effect of Treating Erectile Dysfunction on Management of Systolic Hypertension. The American Journal of Cardiology. 100(3). 459–463. 22 indexed citations

17.

McLaughlin, Trent, et al.. (2005). Evaluation of Erectile Dysfunction Therapy in Patients Previously Nonadherent to Long-Term Medications: A Retrospective Analysis of Prescription Claims. American Journal of Therapeutics. 12(6). 605–611. 27 indexed citations

18.

Samsa, Gregory P., David B. Matchar, James Harnett, & Jerome Wilson. (2005). A Cost-Minimization Analysis Comparing Azithromycin-Based and Levofloxacin-Based Protocols for the Treatment of Patients Hospitalized With Community-Acquired Pneumonia. CHEST Journal. 128(5). 3246–3254. 14 indexed citations

19.

Furuno, Jon P., Joshua P. Metlay, James Harnett, et al.. (2005). Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Pharmacoepidemiology and Drug Safety. 15(1). 1–9. 10 indexed citations

20.

Pasquale, Margaret K., Robert Dufour, Ashish V. Joshi, et al.. (1986). Inefficiencies in osteoarthritis and chronic low back pain management.. PubMed. 19(10). 259–23. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact